Glennon, RA; Dukat, M; Grella, B; Hong, S; Costantino, L; Teitler, M; Smith, C; Egan, C; Davis, K; Mattson, MV. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors Drug Alcohol Depend., 1 Aug 2000, 60 (2), 121–132. 276 kB. https://doi.org/10.1016/S0376-8716(99)00148-9
Glennon, RA; Grella, B; Tyacke, RJ; Lau, A; Westaway, J; Hudson, AL. Binding of β-carbolines at imidazoline I2 receptors: a structure-affinity investigation Bioorg. Med. Chem. Lett., 23 Feb 2004, 14 (4), 999–1002. 131 kB. https://doi.org/10.1016/j.bmcl.2003.11.078 #3b
Barker, SA; Borjigin, J; Lomnicka, I; Strassman, R. LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate Biomed. Chromatogr., 1 Dec 2013, 27 (12), 1690-1700. 929 kB. https://doi.org/10.1002/bmc.2981 LC,MS
Taylor, EW; Nikam, S; Weck, B; Martin, A; Nelson, D. Relative selectivity of some conformationally constrained tryptamine analogs at 5-HT1, 5-HT1A and 5-HT2 recognition sites Life Sci., 19 Oct 1987, 41 (16), 1961–1969. 622 kB. https://doi.org/10.1016/0024-3205(87)90749-1
Barker, SA. N,N-dimethyltryptamine (DMT), an endogenous hallucinogen: Past, present, and future research to determine its role and function Front. Neurosci., 6 Aug 2018, 12 (536). 1.0 MB. https://doi.org/10.3389/fnins.2018.00536 #THBC
Brandt, SD; Moore, SA; Freeman, S; Kanu, AB. Characterization of the synthesis of N,N-dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry Drug Test. Anal., 1 Jul 2010, 2 (7), 330–338. 192 kB. https://doi.org/10.1002/dta.142 #7 MS,NMR
Klein, MT; Dukat, M; Glennon, RA; Teitler, M. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: A comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships J. Pharmacol. Exp. Ther., 1 Jun 2011, 337 (3), 860–867. 1.7 MB. https://doi.org/10.1124/jpet.111.179606 #19